Trust Size
$4M
Peak Price
$412.50
Current Price
$0.54
Return
-94.6%
Price Journey
What Happened
Profusa is a biosensor technology company developing miniaturized sensors that can be implanted under the skin to continuously monitor body chemistry.
Profusa went public through a SPAC merger under the ticker PFSA. The company's tissue-integrated biosensor technology was originally developed with DARPA funding to monitor warfighter health. The stock has struggled with a reverse stock split, and the company faces challenges commercializing its novel sensing platform.
Timeline
2021-12-07
S-1 Registration Filed
🔀 Reverse Stock Split
Reverse split ratio: . Reverse splits are used to avoid delisting but destroy shareholder value through the illusion of a higher stock price.
SEC Filing Details
CIK Number
1859807
Total SEC Filings
251
State of Incorporation
DE
Last Filing Date
2026-03-13
Business Location
New York, NY
Trust/Asset Size
$4M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
📄 SEC Filings
View all EDGAR filings for Profusa